title: Flucloxacillin - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 213/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Flucloxacillin
  Revision Date : 16-11-2020
  |
  Approved: TC, KOH
  |
  Alert
  |
  S4 High risk medicine.
  Antimicrobial Stewardship Team listed this drug as unrestricted.
  |
  Indication
  |
  Treatment of sepsis where infection by Staphylococcus aureus or susceptible coagulase-negative Staphylococci (CoNS) is suspected or confirmed, and other infections caused by susceptible organisms.
  |
  Action
  |
  Bactericidal agent that works by inhibiting the biosynthesis of cell wall mucopeptides. Flucloxacillin is stable against beta-lactamase producing Staphylococci.
  |
  Drug type
  |
  Penicillin antibiotic.
  |
  Trade name
  |
  Flucil, Flucloxacillin sodium monohydrate for injection (DBL), Flubiclox
  |
  Presentation
  |
  500 mg vial, 1000 mg vial, 125 mg/5 mL suspension, 250 mg/5 mL suspension.
  |
  Dose/interval
  |
  |
  |
  | |